CSL's office in Australia: Parkville, VIC
Business Address: 45 Poplar Road, Parkville, VIC 3052
Phone: 61 3 9389 1911
Fax: 61 3 9389 1434
Web: https://www.csl.com
| Type | Public |
|---|---|
| Traded as |
|
| Industry | Biotechnology |
| Founded | 1916 (Federal government department), 1994 (privatised) |
| Headquarters | Parkville, Melbourne, Victoria, Australia (Global), |
| Key people | Paul Perreault (CEO) |
| Products | blood plasma, vaccines, antivenom, other laboratory and medical products |
| Revenue | AUD$10.61 billion (2021) |
| Net income |  USD$1.919 billion (2019) |
| Number of employees | 30,000 person (2022) |
| Divisions |
|
| Website | www.csl.com |
Delivering on promises is what we do at CSL. Over a century ago in Melbourne, Victoria, Australia, we made a promise to save lives and protect the health of people who were stricken with a range of serious and chronic medical conditions. Today, as a leading global biotech company, that same promise has never been stronger. We develop and deliver innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions live full lives. We are driven by our deep passion to serve hundreds of thousands of patients and other stakeholders around the world.